BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29776895)

  • 1. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.
    Lablanche S; Vantyghem MC; Kessler L; Wojtusciszyn A; Borot S; Thivolet C; Girerd S; Bosco D; Bosson JL; Colin C; Tetaz R; Logerot S; Kerr-Conte J; Renard E; Penfornis A; Morelon E; Buron F; Skaare K; Grguric G; Camillo-Brault C; Egelhofer H; Benomar K; Badet L; Berney T; Pattou F; Benhamou PY;
    Lancet Diabetes Endocrinol; 2018 Jul; 6(7):527-537. PubMed ID: 29776895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.
    Chetboun M; Drumez E; Ballou C; Maanaoui M; Payne E; Barton F; Kerr-Conte J; Vantyghem MC; Piemonti L; Rickels MR; Labreuche J; Pattou F;
    Lancet Diabetes Endocrinol; 2023 Jun; 11(6):391-401. PubMed ID: 37105208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
    Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised, prospective, medico-economic nationwide French study of islet transplantation in patients with severely unstable type 1 diabetes: the STABILOT study protocol.
    Lablanche S; David-Tchouda S; Margier J; Schir E; Wojtusciszyn A; Borot S; Kessler L; Morelon E; Thivolet C; Pattou F; Vantyghem MC; Berney T; Benhamou PY
    BMJ Open; 2017 Feb; 7(2):e013434. PubMed ID: 28219959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada.
    Marfil-Garza BA; Imes S; Verhoeff K; Hefler J; Lam A; Dajani K; Anderson B; O'Gorman D; Kin T; Bigam D; Senior PA; Shapiro AMJ
    Lancet Diabetes Endocrinol; 2022 Jul; 10(7):519-532. PubMed ID: 35588757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.
    Borot S; Niclauss N; Wojtusciszyn A; Brault C; Demuylder-Mischler S; Müller Y; Giovannoni L; Parnaud G; Meier R; Badet L; Bayle F; Frimat L; Kessler L; Morelon E; Penfornis A; Thivolet C; Toso C; Morel P; Bosco D; Colin C; Benhamou PY; Berney T;
    Transplantation; 2011 Nov; 92(9):1031-8. PubMed ID: 21926944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.
    Benhamou PY; Franc S; Reznik Y; Thivolet C; Schaepelynck P; Renard E; Guerci B; Chaillous L; Lukas-Croisier C; Jeandidier N; Hanaire H; Borot S; Doron M; Jallon P; Xhaard I; Melki V; Meyer L; Delemer B; Guillouche M; Schoumacker-Ley L; Farret A; Raccah D; Lablanche S; Joubert M; Penfornis A; Charpentier G;
    Lancet Digit Health; 2019 May; 1(1):e17-e25. PubMed ID: 33323237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Toyama T; Oshima M; Jun M; Chin KL; Hawley CM; Zoungas S
    Cochrane Database Syst Rev; 2020 Jul; 8(8):CD009966. PubMed ID: 32803882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study.
    Vantyghem MC; Chetboun M; Gmyr V; Jannin A; Espiard S; Le Mapihan K; Raverdy V; Delalleau N; Machuron F; Hubert T; Frimat M; Van Belle E; Hazzan M; Pigny P; Noel C; Caiazzo R; Kerr-Conte J; Pattou F;
    Diabetes Care; 2019 Nov; 42(11):2042-2049. PubMed ID: 31615852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.
    Tuttle KR; Lakshmanan MC; Rayner B; Busch RS; Zimmermann AG; Woodward DB; Botros FT
    Lancet Diabetes Endocrinol; 2018 Aug; 6(8):605-617. PubMed ID: 29910024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
    Dandona P; Mathieu C; Phillip M; Hansen L; Griffen SC; Tschöpe D; Thorén F; Xu J; Langkilde AM;
    Lancet Diabetes Endocrinol; 2017 Nov; 5(11):864-876. PubMed ID: 28919061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
    Bolinder J; Antuna R; Geelhoed-Duijvestijn P; Kröger J; Weitgasser R
    Lancet; 2016 Nov; 388(10057):2254-2263. PubMed ID: 27634581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.
    Tsoukas MA; Majdpour D; Yale JF; Fathi AE; Garfield N; Rutkowski J; Rene J; Legault L; Haidar A
    Lancet Digit Health; 2021 Nov; 3(11):e723-e732. PubMed ID: 34580055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes.
    Warnock GL; Thompson DM; Meloche RM; Shapiro RJ; Ao Z; Keown P; Johnson JD; Verchere CB; Partovi N; Begg IS; Fung M; Kozak SE; Tong SO; Alghofaili KM; Harris C
    Transplantation; 2008 Dec; 86(12):1762-6. PubMed ID: 19104418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial.
    O'Connell PJ; Hawthorne WJ; Holmes-Walker DJ; Nankivell BJ; Gunton JE; Patel AT; Walters SN; Pleass HC; Allen RD; Chapman JR
    Med J Aust; 2006 Mar; 184(5):221-5. PubMed ID: 16515432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial.
    Pedersen-Bjergaard U; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L
    Lancet Diabetes Endocrinol; 2014 Jul; 2(7):553-61. PubMed ID: 24794703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
    Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.
    Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
    Lancet; 2021 Jun; 397(10291):2275-2283. PubMed ID: 34089660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.